Do the Best Coronary Revascularization Prior TAVR

The presence of coronary artery disease (CAD) in patients with aortic stenosis is high, reaching 50% to70% of cases. This poses a great challenge as to what strategy to use and the things we can do.

Debemos hacer la mejor revasculirazión coronaria previo al TAVIEven though it has been shown complete revascularization is beneficial, it is often difficult to achieve. Instead, reasonable incomplete revascularization should have better evolution (similar to complete revascularization) than incomplete revascularization (ICR) defined as a Residual Syntax Score (rSS) >8 in TAVR. However, there is contradicting information in TAVR.

 

A meta-analysis of 3107 patients included in 6 studies was carried out, with a follow up between 0.7 and 3 years, comparing mortality amongst patients with ICR, reasonable ICR and no CAD disease.


Read also: Elderly Patients with ACS: Clopidogrel or Reduced-Dose Prasugrel?


ICR was associated to higher global mortality, compared against the rest of the groups.  The absence of CAD presented lower mortality compared to ICR (OR 1.85; 95% CI 1.42-2.240; P<0.01), reasonable ICR (OR, 1.69; 95% CI 1.26-2.28; P<0.001) or both groups combined (OR; 1.71; 95% CI, 1.36-2.16; P<0.001).

 

In reasonable ICR patients, there were no differences with those not presenting CAD (OR, 1.11; 95% CI, 0.89-1.39; P=0.33).

 

Conclusion

These outcomes suggest that in patients with coronary artery disease undergoing TAVR, guided rSS revascularization might bring significant benefits as regards mortality. Reasonable revascularization offers a precious opportunity to improve patient prognosis.

 

Commentary

These data suggest we should make an effort to obtain the best revascularization (in one or more procedures) in patients presenting significant CAD that are TAVR candidates.

 

However, note that the present indication poses a great challenge, seeing that it is about a high risk group where most patients are elderly. This involves higher risk in complex PCI, which we should perform taking special care as regards contrast volume, vascular complications and bleeding (the latter notably improved by the use of radial access).

 

Courtesy of Dr. Carlos Fava.

 

Original title: Impact of Coronary Artery Revascularization Completeness on Outcomes of patients With Coronary Artery disease Undergoing Transcatheter Aortic Valve Replacement. A Meta-analysis of Studies Using the residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).

Reference: Guy Witberg, et al . Circ cardiovasc Interv 2018;11:e006000.DOI: 10.1161.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

OPTION Trial: Left Atrial Appendage Closure

Atrial fibrillation ablation is a valid strategy. However, reoccurrence is frequent in these cases, often with asymptomatic presentation. Anticoagulation with warfarin has proven effective in...

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Tricuspid regurgitation (TR) is a condition associated with high morbidity and mortality. Currently, surgery is the recommended treatment; however, it carries a high complication...

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...